glp-1 lawsuit news today 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" Ozempic Lawsuits: Possible Compensation For

While most back pain during GLP-1-based therapy is likely unrelated to the medication and may resolve with conservative management, certain presentations warrant prompt medical evaluation

How do GLP-1 Medications Promote Weight Loss

Not everyone who applies will be approved, and not everyone who gets approved will stay enrolled

[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, et al

Stronger documentationincluding documented weight trajectory, obesity-related comorbidities, or diabetes control metricsimproves approval likelihood

Finan (Novo Nordisk Research Center Indianapolis, USA) and R